Keywords: novo, nordisk, tax, cuts, benefit, reduction, danish
NOVO NORDISK TAX CUTS BENEFIT
Article | 22 March 1993
A reduction in Danish corporation tax benefited Novo Nordisk's 1992 results. The company reports pretax income reached 1.68 billion Danish kroner ($263.1 million), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
